Critical appraisal of ophthalmic ketorolac in treatment of pain and inflammation following cataract surgery
BACKGROUND: The purpose of this review was to provide a critical appraisal of the literature supporting the efficacy of ophthalmic ketorolac (Acuvail(®)) in the treatment of pain and inflammation after cataract surgery.
METHODS: Literature search and expert opinion of the authors.
RESULTS: Recent studies indicate greater intraocular drug levels in the anterior chamber and iris-ciliary body after topical application of Acuvail in comparison with older formulations of ketorolac. A large randomized, multicenter, placebo-controlled study demonstrated significantly less inflammation and pain after cataract surgery using Acuvail.
CONCLUSION: Acuvail appears to be effective in reducing post-cataract surgery pain and inflammation.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2011 |
|---|---|
| Erschienen: |
2011 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:5 |
|---|---|
| Enthalten in: |
Clinical ophthalmology (Auckland, N.Z.) - 5(2011) vom: 16., Seite 751-8 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Reddy, Rahul [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Acuvail® |
|---|
| Anmerkungen: |
Date Completed 14.07.2011 Date Revised 20.10.2021 published: Print-Electronic Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.2147/OPTH.S7633 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM209898615 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM209898615 | ||
| 003 | DE-627 | ||
| 005 | 20231224010634.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231224s2011 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.2147/OPTH.S7633 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0700.xml |
| 035 | |a (DE-627)NLM209898615 | ||
| 035 | |a (NLM)21750608 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Reddy, Rahul |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Critical appraisal of ophthalmic ketorolac in treatment of pain and inflammation following cataract surgery |
| 264 | 1 | |c 2011 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 14.07.2011 | ||
| 500 | |a Date Revised 20.10.2021 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a BACKGROUND: The purpose of this review was to provide a critical appraisal of the literature supporting the efficacy of ophthalmic ketorolac (Acuvail(®)) in the treatment of pain and inflammation after cataract surgery | ||
| 520 | |a METHODS: Literature search and expert opinion of the authors | ||
| 520 | |a RESULTS: Recent studies indicate greater intraocular drug levels in the anterior chamber and iris-ciliary body after topical application of Acuvail in comparison with older formulations of ketorolac. A large randomized, multicenter, placebo-controlled study demonstrated significantly less inflammation and pain after cataract surgery using Acuvail | ||
| 520 | |a CONCLUSION: Acuvail appears to be effective in reducing post-cataract surgery pain and inflammation | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Acuvail® | |
| 650 | 4 | |a cystoid macular edema | |
| 650 | 4 | |a ketorolac tromethamine | |
| 650 | 4 | |a nonsteroidal anti-inflammatory drugs | |
| 650 | 4 | |a postsurgical | |
| 700 | 1 | |a Kim, Stephen Jae |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Clinical ophthalmology (Auckland, N.Z.) |d 2007 |g 5(2011) vom: 16., Seite 751-8 |w (DE-627)NLM186998104 |x 1177-5467 |7 nnns |
| 773 | 1 | 8 | |g volume:5 |g year:2011 |g day:16 |g pages:751-8 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.2147/OPTH.S7633 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 5 |j 2011 |b 16 |h 751-8 | ||